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AbstrAct
Introduction The stepped-wedge cluster randomised 
trial (SW-CRT) is a complex design, for which many 
decisions about key design parameters must be made 
during the planning. These include the number of steps 
and the duration of time needed to embed the intervention. 
Feasibility studies are likely to be useful for informing 
these decisions and increasing the likelihood of the main 
trial’s success. However, the number of feasibility studies 
being conducted for SW-CRTs is currently unknown. This 
review aims to establish the number of feasibility studies 
being conducted for SW-CRTs and determine which 
feasibility issues are commonly investigated.
Methods and analysis Fully published feasibility studies 
for SW-CRTs will be identified, according to predefined 
inclusion criteria, from searches conducted in Ovid 
MEDLINE, Scopus, Embase and PsycINFO. To also identify 
and gain information on unpublished feasibility studies 
the following will be contacted: authors of published 
SW-CRTs (identified from the most recent systematic 
reviews); contacts for registered SW-CRTs (identified from 
clinical trials registries); lead statisticians of UK registered 
clinical trials units and researchers known to work in 
the area of SW-CRTs. Data extraction will be conducted 
independently by two reviewers. For the fully published 
feasibility studies, data will be extracted on the study 
characteristics, the rationale for the study, the process 
for determining progression to a main trial, how the 
study informed the main trial and whether the main trial 
went ahead. The researchers involved in the unpublished 
feasibility studies will be contacted to elicit the same 
information. A narrative synthesis will be conducted and 
provided alongside a descriptive analysis of the study 
characteristics.
Ethics and dissemination This review does not require 
ethical approval, as no individual patient data will be used. 
The results of this review will be published in an open-
access peer-reviewed journal.
IntroductIon
The stepped-wedge cluster randomised trial
The stepped-wedge cluster randomised 
trial (SW-CRT) is seeing an unprecedented 
increase in its use.1–4 For this design, clusters 
are randomised to start the intervention at 
different time points. All of the clusters start 
the trial not receiving the intervention, and 
then switch to the intervention at their allo-
cated start time, until by the end of the trial 
all of the clusters are receiving the interven-
tion figure 1.5
There are several appeals of the SW-CRT. 
One of the main appeals being that it allows 
a staggered introduction of the intervention, 
allowing clusters to act as their own control 
and for all clusters to eventually receive the 
intervention.2 6 The introduction of the 
intervention is also randomised, making this 
design more desirable than a simple (non-ran-
domised) before-and-after design, which 
are known to be confounded by temporal 
trends that cannot be adjusted for.7 In addi-
tion, there are occasions when the SW-CRT is 
more efficient than a parallel CRT, requiring 
a smaller sample size and fewer clusters.7 8 
The SW-CRT can thus allow the experimental 
assessment of the effectiveness of certain 
interventions that, due to practical, logistical 
or financial reasons, it may not be possible 
to assess using another design of trial.5 7 9 An 
example of a study for which the SW-CRT was 
considered the best option is the Sedation 
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Protocol
strengths and limitations of this study
 ► This review will be the first to provide an insight 
into how feasibility studies are being used to 
inform  stepped-wedge cluster randomised trials 
(SW-CRTs).
 ► This review will identify both published and 
unpublished feasibility studies for SW-CRTs.
 ► To ensure a robust review and minimise potential 
bias, the search strategy and inclusion and exclusion 
criteria have been prespecified.
 ► Although steps have been taken to minimise 
potential sources of bias, selection bias may be 
introduced through the exclusion of non-English 
language studies.
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Figure 1 Schematic of an example stepped-wedge cluster randomised trial (SW-CRT), with four steps and one cluster 
switching from control (white) to the intervention (light blue) at each time point. A recruitment period (light green) has been 
included prior to the first measurement period, as well as a bedding-in period (dark blue) during which the intervention will be 
embedded within the cluster. A cross-sectional sample is taken during each measurement period, at the time point indicated by 
the orange line, from which the outcome measure is obtained. Not all SW-CRTs follow the design shown. For example, some 
SW-CRTs may not include a recruitment or bedding-in period and others may be of a cohort design.
AND Weaning In CHildren (SANDWICH) trial.10 Details 
of the reasons for this choice of design and the decision 
processes related to this choice are described in figure 2.
trial decision process in the sW-crt
The staggered nature of the introduction of clusters to 
the intervention in a SW-CRT requires many decisions to 
be made during the design process, such as the number 
of start times and the length of time between start times.7 
For example there may be logistical constraints that mean 
it is only feasible to switch a certain number of clusters at 
once, or the intervention may take a while to embed in 
a cluster, in which case the length of time between start 
times might need to be sufficiently long to allow for this.7 
Alternatively, the trial might need to be completed within 
a fixed funding period, in which case the step length will 
need to be short enough to allow all clusters to switch 
within this period. These decisions are in addition to 
those that must be made for a standard CRT and are 
unlikely to be able to be informed by previous studies. It is 
known that, although advantageous in some respects, the 
staggered introduction of the intervention may increase 
the complexity of the trial in both practical and statistical 
terms.6 7 Some of the issues associated with a staggered 
implementation are being investigated as part of a feasi-
bility study for the SANDWICH trial, details of which are 
given in figure 2.
What feasibility and pilot studies may offer
The terms pilot and feasibility study are often used 
interchangeably to describe a small scale study, that 
is conducted prior to the main trial and which aims to 
guide the planning or design of the trial or to confirm 
its feasibility.11–14 When designing a trial, decisions may 
be informed by previous trials, systematic reviews, routine 
data and so on, but there may be aspects of the trial that 
require additional information which might only be 
obtained through the use of a feasibility or pilot study.13 
Pilot or feasibility studies are becoming the norm prior 
to a definitive individually randomised trial, and test trial 
factors such as recruitment, retention and acceptability of 
the intervention.15 16
Cluster randomised trials (CRTs) are typically 
larger and more expensive, and due to their addi-
tional complexity, tend to need more assumptions and 
decisions to be made at the design stage than for an 
individually randomised trial.13 17 Each aspect of the 
design that is assessed at an individual level, now needs 
to also be assessed at the cluster level. These may include 
recruitment and retention rates or the acceptability of 
the intervention to both the individuals and the clus-
ters. Specifically for CRTs, an estimate of the extent 
of variation between clusters (intracluster correlation 
coefficient (ICC)) is needed to calculate the required 
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Figure 2 A case study of the SANDWICH stepped-wedge cluster randomised trial.
sample size. However, Eldridge et al17 have shown that 
feasibility studies to investigate ICCs for CRTs will often 
have insufficient accuracy, unless the feasibility study is 
almost as large as the main trial.
Feasibility studies may be of even greater potential 
benefit for SW-CRTs than they are for standard CRTs, 
as numerous additional decisions must be made. These 
include determining the number of clusters it is feasible 
to switch to the intervention at each step and the length 
of time between each step needed to embed the interven-
tion, ensuring that the full effect of the intervention is 
realised and enough participants are recruited for each 
stage of the trial.9
Previous systematic reviews have investigated the 
reasons why a pilot or feasibility study might be under-
taken for a randomised controlled trial (RCT),11 15 18 
but these reviews are unlikely to have captured many 
pilot or feasibility studies for SW-CRTs. In addition, 
no published systematic reviews of SW-CRTs have 
included feasibility studies, so it is not currently known 
to what extent feasibility studies are being conducted 
for SW-CRTs nor what issues these studies are being 
designed to investigate.
What our review will achieve
We aim to identify what feasibility work is being 
conducted for SW-CRTs. This will be achieved through 
a systematic review of the published literature, which 
will identify published feasibility studies for SW-CRTs. 
However, as feasibility studies often go unpublished, 
we will extend our review to identify unpublished feasi-
bility studies. This will be achieved by contacting the 
authors of published and registered SW-CRTs, lead stat-
isticians of UK registered clinical trials units (CTUs) 
and researchers who are known by the authors to work 
in the area of SW-CRTs.
objEctIvEs
The overarching aims of this review are to determine 
the number of feasibility studies being conducted for 
SW-CRTs and how these studies are being used to inform 
the subsequent SW-CRTs. Specifically, our objectives are 
to:
1. Systematically identify published feasibility studies for 
SW-CRTs;
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box 1 Example search strategy for ovid MEdLInE
1. ‘pilot*’.mp
2. ‘feasibil*’.mp
3. 1 OR 2
4. ‘step* wedge*’.mp
5. ‘step*wedge*’.mp
6. ‘delay* intervention’.mp
7. ‘experimental* staged introduction’.mp
8. (‘one* direction* crossover design’ OR ‘one* direction* cross* over 
design’).mp
9. (‘incremental* recruitment’ OR ‘incremental* introduction’ OR 
‘incremental* implementation’ OR ‘incremental* allocation’).mp
10. (‘phased* recruitment’ OR ‘phased* introduction’ OR ‘phased* 
implementation’ OR ‘phased* allocation’).mp
11. (‘staggered* recruitment’ OR ‘staggered* introduction’ OR 
‘staggered* implementation’ OR ‘staggered*allocation’).mp
12. (‘stepwise* recruitment’ OR ‘stepwise* introduction’ OR ‘stepwise* 
implementation’ OR ‘stepwise*allocation’).mp
13. (‘step*wise* recruitment’ OR ‘step*wise* introduction’ OR 
‘step*wise* implementation’ OR ‘step*wise*allocation’).mp
14. (‘delayed* recruitment’ OR ‘delayed* introduction’ OR ‘delayed* 
implementation’ OR ‘delayed*allocation’).mp
15. or/4–14
16. 3 AND 15
17. limit 16 to English language
2. Identify unpublished feasibility work that has been 
conducted or is planned to take place prior to a SW-
CRT;
3. Extract information on the design characteristics 
and rationale for these feasibility studies, as well as 
how these studies inform the main trial and how the 
decision is made as to whether to progress to the main 
trial.
MeThods
A two-pronged approach will be implemented to iden-
tify feasibility studies for SW-CRTs. Published feasibility 
studies will be identified through a systematic review of 
the literature, whereas unpublished feasibility studies will 
be identified by contacting researchers who may have 
been involved in, or have knowledge of, feasibility studies 
for SW-CRTs that have been conducted but which have 
not yet been published.
search strategy
Identification of published feasibility studies for SW-CRTs
We will identify eligible feasibility studies for SW-CRTs, 
published in English, via electronic searches of the online 
published databases Ovid MEDLINE (1946–present), 
Scopus (1966–present), Embase (1947–present) and 
PsycINFO (1967–present). The initial search strategy 
will include a combination of MeSH terms and keywords 
specific to each bibliographic database. An example 
search strategy is outlined in Box 1 and is based on previ-
ously published search strategies.1–3 11 15
The titles and abstracts for the identified studies will 
be screened for eligibility by two reviewers independently 
in a random order, with full-text articles being obtained 
for potentially eligible studies and the same duplicate 
method of assessment used. Any studies which are not 
found to be eligible will be excluded and the reason 
for exclusion noted. Any differences of opinion will be 
resolved by a third reviewer if required. Authors will be 
contacted if any further information is required and we 
will aim to access any published or unpublished protocols 
for each of the identified feasibility studies.
Reference lists of the identified studies will also be 
checked for potentially eligible studies. Any additional 
published feasibility studies for SW-CRTs which are known 
to the authors, but which are not identified during the 
database searches, will also be included and assessed for 
eligibility. Records will be managed using Refworks refer-
ence management software.
Identification of unpublished feasibility studies for sW-crts
Feasibility studies for SW-CRTs might not always be 
published. In an attempt to identify the majority of feasi-
bility studies for SW-CRTs, our systematic review will be 
extended to allow inclusion of unpublished feasibility 
studies. This will be achieved in the following ways:
 ► Unpublished feasibility work for published SW-CRTs 
will be identified from the SW-CRTs reported in the 
most recent systematic reviews. The trial reports and 
references will be examined for evidence of feasibility 
work. The authors of these trials will then be contacted 
to identify whether any unreported feasibility work 
was conducted.
 ► Feasibility work that has been conducted for SW-
CRTs that are yet to be published will be sought by 
contacting the lead statisticians of CTUs, researchers 
working in the area of stepped-wedge trials, as well as 
through searches of clinical trials registries.
Inclusion and exclusion criteria
For the systematic review of published feasibility studies, 
eligible studies will be full reports or protocols of feasi-
bility studies for SW-CRTs published during the period 
covered by the searched databases (1946–present). For 
the unpublished feasibility studies, no publications will be 
required to qualify for inclusion.
The definition of, and distinction between feasibility 
and pilot studies is not always clear, with the terms often 
being used interchangeably11 12 and conflicting definitions 
existing for the distinction between the terms.14 19 For the 
purpose of this review (including both published and 
unpublished studies), a feasibility study will be defined 
as a study, with clearly defined aims and objectives, which 
intends to ascertain the feasibility of a planned SW-CRT, 
through the assessment of issues other than solely the 
effectiveness and refinement of the intervention, such 
as investigating recruitment issues. Since pilot studies 
will also often investigate issues affecting the feasibility 
of the main trial, they will be considered to be a type of 
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feasibility study for the purpose of this review, provided 
they satisfy the criteria of a feasibility study.
The feasibility study itself does not need to be of a 
stepped-wedge design, or even randomised, as the design 
will depend on the objectives of the study. However, the 
study should, through focused objectives, make it clear 
how the findings of the feasibility study will inform the 
main study, which must be intended to be of an SW-CRT 
design. An SW-CRT will be defined as a randomised 
trial, which randomises clusters and which has two or 
more steps (time-points at which clusters change treat-
ment group). Studies where the planned definitive trial 
is individually randomised, has a bidirectional cross-over 
design or is non-randomised, will be excluded. Neither 
the published nor the unpublished feasibility studies will 
be limited to healthcare settings.
The researchers involved in the unpublished feasibility 
studies that we identify will be contacted to gain the infor-
mation required to determine eligibility.
dAtA ExtrActIon
Data for eligible published feasibility studies will be 
extracted by two reviewers independently and in random 
order using a data extraction form that will have been 
tested on a small number of studies, before being refined 
and finalised. Any differences will be resolved though 
discussion with a third reviewer. Extracted data will be 
managed in Microsoft Excel V.2013.
For the eligible unpublished feasibility studies, data will 
be obtained through semistructured interviews with the 
researchers involved in the studies. This will be conducted 
by a single reviewer. The same data will be collected for 
the unpublished feasibility studies as is extracted for the 
published feasibility studies.
data extraction of trial characteristics
Data will be extracted on aspects of the design of the feasi-
bility study, including the recruitment, randomisation, 
blinding and overall design (parallel, stepped-wedge, 
etc), as well as how exposure to the intervention is experi-
enced at an individual level. For example, in some studies 
subjects might receive both the control and intervention 
conditions, whereas in others they might only experience 
the one condition. Data will also be extracted on how 
each feasibility study defines itself (either as a pilot or 
feasibility study), the size of the feasibility study and how 
the chosen sample size is justified.
data extraction of study rationale
Data will be extracted on the rationale for conducting 
a feasibility study prior to the main trial. This will be 
achieved by extracting the specific aims of each study 
and categorising them into process, resource, manage-
ment and scientific motivations.20 These categories will 
be defined as:
 ► Process—assesses the feasibility of the steps that need 
to take place during the main study. This will include 
the estimation of recruitment, consent and retention 
rates, testing of the process and acceptability of the 
randomisation procedure, testing of the exclusion 
criteria, identification of barriers to recruitment, 
adherence and so on. Some of these will be specific to 
the SW-CRT, for example, the recruitment rates per 
measurement period, which will determine the length 
of time between steps, whereas others will be more 
generic.
 ► Resource—assesses the time and budget problems 
that may occur during the main trial. This may include 
the time taken for data collection for example, time 
taken to mail or fill out forms/surveys and have 
them returned or the time taken for data entry to be 
completed. The human resources available may also 
be a consideration, ensuring that the right people 
are available with the required expertise. Specific to 
SW-CRT, these aims might include the length of time 
required to roll out the intervention or the time taken 
to acquire the necessary permissions from each of the 
clusters.
 ► Management—assesses the potential for human and 
data optimisation problems, such as the feasibility 
of international collaborations and across site 
coordination for multicentre trials.
 ► Scientific motivations—assesses the scientific 
processes such as treatment safety and acceptability 
and estimation of the ICC (not recommended17), 
potential effectiveness and variance parameters.
In addition, the aims of each feasibility study will be subdi-
vided into aims that are specific to the SW-CRT and those 
which will be common with other trial designs.
data extraction of progression to main trial
Data will be extracted on the process for deciding 
whether the study will progress to the main trial. This 
will include the type of analysis conducted, either 
hypothesis testing or descriptive, how much emphasis is 
put on the results of any hypothesis tests and the criteria 
used for determining success (main trial is considered 
feasible). Information on any hard or soft stopping 
rules that are in place for the feasibility studies will also 
be extracted.
data extraction of main trial characteristics
Data will be extracted on the details of the main trials 
that follow each of the feasibility studies; whether it goes 
ahead, how the feasibility study has informed or made 
changes to the main trial and whether any of the partici-
pants who took part in the feasibility study also took part 
in the main trial.
AnALysIs of rEsuLts
We will present a narrative synthesis of our findings, as 
well as a descriptive analysis of the study characteristics of 
each of the eligible feasibility studies that we identify for 
inclusion in the review.
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EthIcs And dIssEMInAtIon
As no individual patient data will be used, this review does 
not require ethical approval. We intend on presenting the 
findings of this review in an open-access peer-reviewed 
publication in an appropriate journal. We also intend on 
disseminating the findings through presentations at rele-
vant conferences.
dIscussIon
Although several reviews have been conducted in the 
area of stepped-wedge trials,1–4 21 22 none have investi-
gated the use of feasibility studies for SW-CRTs. Due to 
their complexity, there are likely to be many issues that 
will affect the feasibility of SW-CRTs, some of which may 
be common across studies. However, it has yet to be 
reported how often feasibility work is being conducted 
prior to SW-CRTs, nor what feasibility issues these studies 
have been designed to inform. We aim to use our review 
to determine how many feasibility studies are conducted 
for SW-CRTs and what issues these studies have been 
designed to investigate. From the number of feasibility 
studies that we identify, we will be able to infer the rough 
order of magnitude of SW-CRTs which have some form 
of feasibility work conducted prior to the main trial. This 
will provide an estimate of how often feasibility studies 
are conducted prior to an SW-CRT.
By prespecifying our search strategy, the inclusion and 
exclusion criteria and ensuring that two reviewers inde-
pendently review all studies in a randomised order, we 
aim for our review to be robust, minimising potential 
sources of bias. Since the term ‘stepped wedge’ has not 
been universally used to describe a trial of this design, 
we have included in our search strategy other terms used 
to describe this design, terms which have been used in 
previous reviews.1–4 22 However, there still remains the 
potential for selection bias in our review, as only trials 
using one of these terms will be included, which will 
exclude any SW-CRTs using alternative terminology. We 
may also introduce selection bias through the exclu-
sion of non-English language studies, although there is 
evidence that this has a minimal effect.23
Our review would be limited if relying solely on 
published feasibility studies for SW-CRTs, as many will 
not have been published, particularly if proceeding to 
the main trial was regarded as infeasible. However, by 
extending our systematic review to identify unpublished 
feasibility studies for SW-CRTs, we will be able to widen the 
reach of our review. We will contact authors of published 
SW-CRTs and researchers known to be working in the 
area of SW-CRTs to determine if they have knowledge of 
additional studies that we can include in our review. It 
may be anticipated that there will be few feasibility studies 
for SW-CRTs. However, with the various methods we 
plan on implementing, we expect to be able to identify 
the majority of those feasibility studies for SW-CRTs that 
do exist. We have already identified a handful of these 
studies from a small scoping review and some studies that 
we already knew about. We are therefore optimistic that 
our full review will be able to identify further studies.
concLusIon
This review is the first in a series of related projects inves-
tigating the feasibility of SW-CRTs. It will determine the 
number of feasibility studies being conducted to inform 
SW-CRTs and identify the feasibility issues that are being 
investigated and how these studies are informing the main 
SW-CRTs. This will provide an insight into how feasibility 
studies can benefit SW-CRTs. Future work will identify 
the feasibility issues being encountered in SW-CRTs and 
ultimately lead to the development of guidance on how 
feasibility studies for SW-CRTs can be conducted.
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